» Articles » PMID: 32905189

Reflections on Treatment of COVID-19 with Traditional Chinese Medicine

Overview
Journal Chin Med
Publisher Biomed Central
Date 2020 Sep 9
PMID 32905189
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

Coronavirus disease 2019 (COVID-19) pandemic is spreading rapidly around the globe. By the establishment of an integrative system combining both traditional Chinese medicine (TCM) and western medicine, China has achieved good clinical efficacy in the prevention and control of the pandemic. The advantages of TCM in the treatment of COVID-19 include effective relief of symptoms, retarding the development from mild and moderate to severe, improvement of cure rate, reducing death rates, and promotion of rehabilitation. Besides, according to the different severity levels of individual cases, the National Health Commission of the People's Republic of China issued treatment guidelines that provide corresponding prescriptions for patients. From the perspective of TCM, this review aims to analyze the role of a variety of TCM prescriptions in the treatment of COVID-19, focusing on the analysis of the "Three TCM prescriptions and three medicines" recommended by the Chinese authorities during the pandemic. We expect that this review will provide insights into the prevention and treatment of COVID-19 with TCM.

Citing Articles

Traditional Chinese medicine as a protective strategy against chemotherapy-induced cardiotoxicity: An overview of the literature.

Wang J, Shao H, Zhang Y, Ge T, Chen X, Mou X J Tradit Complement Med. 2025; 15(2):107-118.

PMID: 40060147 PMC: 11883632. DOI: 10.1016/j.jtcme.2024.06.010.


Interferon Point Alteration in Hospitalized Patients with and Without COVID-19.

Rezvani Habibabadi M, Saghaei M, Ghahramani A, Habibzadeh Siahroadkolaee M, Fattahpour S, Hashemi S Med Acupunct. 2024; 36(6):343-349.

PMID: 39712526 PMC: 11659459. DOI: 10.1089/acu.2023.0095.


Ayurvedic and Chinese Herbs against Coronaviruses.

Gasmi A, Kanwal S, Oliinyk P, Lysiuk R, Shanaida M, Benahmed A Curr Pharm Des. 2024; 30(21):1681-1698.

PMID: 38685809 DOI: 10.2174/0113816128269864231112094917.


CPMI-ChatGLM: parameter-efficient fine-tuning ChatGLM with Chinese patent medicine instructions.

Liu C, Sun K, Zhou Q, Duan Y, Shu J, Kan H Sci Rep. 2024; 14(1):6403.

PMID: 38493251 PMC: 10944515. DOI: 10.1038/s41598-024-56874-w.


Temporal and Emotional Variations in People's Perceptions of Mass Epidemic Infectious Disease After the COVID-19 Pandemic Using Influenza A as an Example: Topic Modeling and Sentiment Analysis Based on Weibo Data.

Dai J, Lyu F, Yu L, He Y J Med Internet Res. 2023; 25:e49300.

PMID: 37917144 PMC: 10654902. DOI: 10.2196/49300.


References
1.
Zhao W, Li K, Zhang S, Fu Y, Shi X . [The effect of Xuebijing injection on immune regulation in SIRS patients]. Sichuan Da Xue Xue Bao Yi Xue Ban. 2014; 45(5):863-5. View

2.
Wu X, Wang S, Lu J, Jing Y, Li M, Cao J . Seeing the unseen of Chinese herbal medicine processing (): advances in new perspectives. Chin Med. 2018; 13:4. PMC: 5773022. DOI: 10.1186/s13020-018-0163-3. View

3.
Akour A . Probiotics and COVID-19: is there any link?. Lett Appl Microbiol. 2020; 71(3):229-234. PMC: 7300613. DOI: 10.1111/lam.13334. View

4.
An X, Wu W, Lai H, Yang L, Tan X, Huang Z . [Research progress in molecular pharmacognosy of Pogostemon cablin]. Zhongguo Zhong Yao Za Zhi. 2019; 44(22):4781-4785. DOI: 10.19540/j.cnki.cjcmm.20190729.105. View

5.
Dhar D, Mohanty A . Gut microbiota and Covid-19- possible link and implications. Virus Res. 2020; 285:198018. PMC: 7217790. DOI: 10.1016/j.virusres.2020.198018. View